Long-term follow-up of chronic active hepatitis of moderate severity
- PMID: 680585
- PMCID: PMC1412017
- DOI: 10.1136/gut.19.6.510
Long-term follow-up of chronic active hepatitis of moderate severity
Abstract
A group of patients with only moderately active chronic hepatitis has been studied. The follow-up was long (mean 87 months). All patients except one were treated with prednisone and/or azathioprine. Of the hepatitis B virus positive patients two-thirds developed cirrhosis between the second and fifth year of evolution, while in the hepatitis B negative group this occurred in less than one-third. The transition to cirrhosis was clinically silent. The patients were all allowed to do their normal work except in the terminal stages of cirrhosis. Five patients died of causes related to the disease: three patients with cirrhosis and hepatocellular carcinoma, one with gallbladder carcinoma, and one from bleeding varices. The high incidence of tumour, especially liver-cell carcinoma, may be due to a cumulative effect of the presence of hepatitis B virus, cirrhotic transformation, and immuno-suppression. The other patients are currently in apparently good health.
Similar articles
-
[Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].Med Klin. 1972 Apr 14;67(15):527-34. Med Klin. 1972. PMID: 5053009 German. No abstract available.
-
[Immediate and long-term effects of therapeutic immunodepression in active chronic hepatitis. Prospective study of the action of prednisone and azathioprine].Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1981 Jul-Aug;33(4):371-82. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1981. PMID: 6120554 Romanian. No abstract available.
-
[Long-term clinical observations of chronic active hepatitis HBsAg (+)].Pol Arch Med Wewn. 1992 Oct;88(4):250-5. Pol Arch Med Wewn. 1992. PMID: 1488326 Polish.
-
[Chronic hepatitis].Recenti Prog Med. 1976 May;60(5):489-509. Recenti Prog Med. 1976. PMID: 798245 Review. Italian. No abstract available.
-
[Therapy of chronic hepatitis (author's transl)].Leber Magen Darm. 1981 Apr;11(2):73-80. Leber Magen Darm. 1981. PMID: 6164895 Review. German.
Cited by
-
Epidemiology and treatment of autoimmune hepatitis.Hepat Med. 2012 Mar 16;4:1-10. doi: 10.2147/HMER.S16321. Hepat Med. 2012. PMID: 24367228 Free PMC article. Review.
-
Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.World J Gastroenterol. 2009 May 21;15(19):2314-28. doi: 10.3748/wjg.15.2314. World J Gastroenterol. 2009. PMID: 19452572 Free PMC article. Review.
-
Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.Clin Exp Immunol. 1981 Feb;43(2):246-53. Clin Exp Immunol. 1981. PMID: 7273479 Free PMC article.
-
Prognostic significance of bridging necrosis in chronic active hepatitis.Gastroenterol Jpn. 1983 Dec;18(6):577-84. doi: 10.1007/BF02774698. Gastroenterol Jpn. 1983. PMID: 6671513
-
Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.Am J Gastroenterol. 1995 May;90(5):771-6. Am J Gastroenterol. 1995. PMID: 7537444 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources